[1]
Daniel Sagan, “THE EFFECTS OF SGLT2 INHIBITORS IN CARDIOVASCULAR PROTECTION: A REVIEW OF MECHANISTIC INSIGHTS AND CLINICAL EVIDENCE”, IJITSS, vol. 3, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5476.